Alogliptin in Patients with Type 2 Diabetes on Metformin and Sulfonylurea Therapies in the EXAMINE Trial
White WB, Heller SR, Cannon CP, et al.
The American Journal of Medicine. Publ. Online March 26, 2018.
Leggi
Breaking news
Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury
Chapman AR, Shah ASV, Lee KK, et al.
Circulation. 2018;137:1236-45
Leggi
FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices
27/03/2018
Leggi
A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
de Groot S, Enters-Weijnen CF, Geelhoed-Duijvestijn PH, Kanters TA
BMJ Open. 2018;8:e019864
Leggi
Adult care providers’ perspectives on the transition to adult care for emerging adults with Type 1 diabetes: a cross-sectional survey
Michaud S, Dasgupta K, Bell L, et al.
Diabetic Medicine. Pub. online March 25, 2018.
Leggi
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
Pratley RE, Aroda VR, Lingvay I, et al.
The Lancet Diabetes & Endocrinology. 2018;6(4):275-86
Leggi
Screening thresholds: one size does not fit all
The Lancet Diabetes & Endocrinology. April 2018; 6 (4): 259.
Leggi
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
Waldman B, Ansquer J-C, Sullivan DR, et al.
The Lancet Diabetes & Endocrinology. 2018;6(4):310-8
Leggi
Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
Hales CM, Fryar CD, Carroll MD, et al.
JAMA. Published online March 23, 2018.
Leggi
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study
Herrington WG, Alegre-Díaz J, Wade R, et al.
The Lancet Diabetes & Endocrinology. Pub. online March 19, 2018.
Leggi